A Randomized, Double-Blind, Placebo Controlled Proof-of-Concept Study Investigating the Safety and Efficacy of ZT-031 on Hip Fracture Healing in Men and Postmenopausal Women With Intertrochanteric Fracture of the Hip.

Trial Profile

A Randomized, Double-Blind, Placebo Controlled Proof-of-Concept Study Investigating the Safety and Efficacy of ZT-031 on Hip Fracture Healing in Men and Postmenopausal Women With Intertrochanteric Fracture of the Hip.

Withdrawn prior to enrolment
Phase of Trial: Phase II

Latest Information Update: 05 Jun 2009

At a glance

  • Drugs ZT 031 (Primary)
  • Indications Hip fracture; Osteoporosis; Postmenopausal osteoporosis
  • Focus Therapeutic Use
  • Acronyms SHIFT
  • Most Recent Events

    • 05 Jun 2009 Actual initiation date (December 2008) added as reported by ClinicalTrials.gov.
    • 05 Jun 2009 Status changed from not yet recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
    • 25 Nov 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top